Carmat, leading company in pioneering solutions to revolutionise the healthcare industry, is the designer and developer of the world’s most advanced total artificial heart project, aiming to provide a therapeutic alternative for people suffering from end-stage biventricular heart failure.
In order to ensure a better therapeutic follow-up, CARMAT has initiated the development of a remote monitoring solution to record the cardiac parameters of patients as well as the CARMAT heart function data remotely.
WiSNAM has been selected to design a new gateway for the extraction of data from the controller of the Total Artificial Heart (TAH). The project has started in mid 2018 and the solutions we are designing will be ready for clinical trials at the end of 2018.
By pursuing the development of its total artificial heart, CARMAT intends to overcome the well-known shortfall in heart transplants for the tens of thousands of people suffering from irreversible end-stage heart failure, the most serious disease among the 20 million cardiopathic patients in Europe and the United States.
And WiSNAM will be by CARMAT side.